Zachary Leibovit-Reiben
5PUBLICATIONS
36CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 27, 2026
TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris.Alyssa Stockard, Zachary Leibovit-Reiben, Bowen Hu
|Jun 08, 2025
TNF-α Inhibitor Associated Psoriasis in Rheumatoid Arthritis and Inflammatory Bowel Disease Patients: A Disproportionality Analysis Using the FDA Adverse Event Reporting System.Zachary Leibovit-Reiben, Hannah Godfrey, Patrick Jedlowski
|Feb 14, 2025
Repurposing the composite assessment of index lesion severity scoring system in cutaneous lichen planus.Nan Zhang, Alyssa L Stockard, Zachary Leibovit-Reiben
|Jun 26, 2024
Alopecia associated with the use of semaglutide and tirzepatide: A disproportionality analysis using the FDA adverse event reporting system (FAERS) from 2022 to 2023.Hannah Godfrey, Zachary Leibovit-Reiben, Patrick Jedlowski
|Aug 15, 2023
Photophobia Contributes to Migraine-Associated Disability and Reduced Work Productivity: Results From the American Registry for Migraine Research (ARMR).Zachary Leibovit-Reiben, Gina Dumkrieger, David W Dodick
Pageof 1
Frequent Collaborators
2 joint publications
Hannah Godfrey
2 joint publications
Nan Zhang
2 joint publications
Alyssa Stockard
2 joint publications
Aaron R Mangold
2 joint publications
Mark R Pittelkow
2 joint publications
Samantha Zunich
1 joint publications
Johann E Gudjonsson
1 joint publications
Jacob A Kechter
1 joint publications
Caitlin M Brumfiel
1 joint publications
Puneet Bhullar
